Have a personal or library account? Click to login
Cancer-associated thromboembolism: could direct-acting oral anticoagulants be a promising therapeutic option? Literature review Cover

Cancer-associated thromboembolism: could direct-acting oral anticoagulants be a promising therapeutic option? Literature review

Forum of Clinical Oncology
Volume 11 (2020): Issue 1 (March 2020)
By: Paraskevi Savvari  
Open Access
|Sep 2020

Authors

Paraskevi Savvari

Paraskevi.Savvari@pfizer.com

First Department of Internal Medicine, Henry Dunant Medical Centre, Athens, Greece
DOI: https://doi.org/10.2478/fco-2019-0009 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Journal RSS Feed
Language: English
Page range: 22 - 28
Submitted on: Mar 25, 2019
|
Accepted on: Feb 28, 2020
|
Published on: Sep 8, 2020
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
cancer,
venous thromboembolic event,
CAT,
direct oral anticoagulant drugs,
DOACs
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology

© 2020 Paraskevi Savvari, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 11 (2020): Issue 1 (March 2020)Next article